Cargando…

Multi-Omics Analysis in β-Thalassemia Using an HBB Gene-Knockout Human Erythroid Progenitor Cell Model

β-thalassemia is a hematologic disease that may be associated with significant morbidity and mortality. Increased expression of HBG1/2 can ameliorate the severity of β-thalassemia. Compared to the unaffected population, some β-thalassemia patients display elevated HBG1/2 expression levels in their r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Guoqiang, Zhang, Haokun, Lin, Anning, Wu, Zhen, Li, Ting, Zhang, Xumin, Chen, Hongyan, Lu, Daru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911073/ https://www.ncbi.nlm.nih.gov/pubmed/35269949 http://dx.doi.org/10.3390/ijms23052807

Ejemplares similares

Prime Editor 3 Mediated Beta-Thalassemia Mutations of the HBB Gene in Human Erythroid Progenitor Cells
por: Zhang, Haokun, et al.
Publicado: (2022)

HBB-deficient Macaca fascicularis monkey presents with human β-thalassemia
por: Huang, Yan, et al.
Publicado: (2019)

Two Rare Pathogenic HBB Variants in a Patient with β-Thalassemia Intermedia
por: Hançer, Veysel Sabri, et al.
Publicado: (2020)

Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing
por: Zhang, Haokun, et al.
Publicado: (2022)

Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
por: Xu, Peng, et al.
Publicado: (2015)

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia
por: Patsali, Petros, et al.
Publicado: (2020)

PB2239: DOES SIZE MATTER? THREE NEW DELETIONS IN THE HBB GENE CAUSE Β0-THALASSEMIA
por: Ropero, P., et al.
Publicado: (2022)

Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus
por: Kountouris, Petros, et al.
Publicado: (2020)

Evidence of new intragenic HBB haplotypes model for the prediction of beta-thalassemia in the Malaysian population
por: Aziz, Nur-Aisyah, et al.
Publicado: (2021)

Compound heterozygous β(+) β(0) mutation of HBB gene leading to β-thalassemia major in a Gujarati family — A case study
por: Chaudhary, Spandan, et al.
Publicado: (2016)

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
por: Piga, Antonio, et al.
Publicado: (2022)

Does the c.-273T>C variant in the upstream region of the HBB gene cause a thalassemia phenotype?
por: Dastsooz, Hassan, et al.
Publicado: (2017)

A Cross-Sectional Study of Detection of Beta Globin (HBB) Haplotypes Among Beta Thalassemia Patients
por: Alsamiri, Ali, et al.
Publicado: (2021)

Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
por: Psatha, Nikoletta, et al.
Publicado: (2018)

Effect of Tumor Necrosis Factor-Alpha on Erythropoietin- and Erythropoietin Receptor-Induced Erythroid Progenitor Cell Proliferation in β-Thalassemia/Hemoglobin E Patients
por: Tanyong, Dalina I, et al.
Publicado: (2015)

XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia
por: Guillem, Flavia, et al.
Publicado: (2019)

A comparison of intrauterine hemopoietic cell transplantation and lentiviral gene transfer for the correction of severe β-thalassemia in a HbbTh3/+ murine model
por: Dighe, Niraja M., et al.
Publicado: (2018)

Epigenetic plasticity of erythroid progenitors
por: Brand, Marjorie
Publicado: (2021)

Hb Knossos (HBB: c.82G > T), β-globin CD 5 (−CT) (HBB: c.17_18delCT) and δ-globin CD 59 (−a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia
por: Moassas, Faten, et al.
Publicado: (2019)

SOX6 Downregulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells
por: Li, Jing, et al.
Publicado: (2017)

On the simulation of Zbb and Hbb events at LHC
por: González de la Hoz, S, et al.
Publicado: (2001)

The role of erythrocytes and erythroid progenitor cells in tumors
por: Zhang, Hao, et al.
Publicado: (2022)

Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia
por: Chen, Nianhang, et al.
Publicado: (2020)

Impaired Terminal Erythroid Maturation in β(0)-Thalassemia/HbE Patients with Different Clinical Severity
por: Suriyun, Thunwarat, et al.
Publicado: (2022)

CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia
por: Yang, Yi, et al.
Publicado: (2021)

A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β‐thalassemia major
por: Fanis, Pavlos, et al.
Publicado: (2019)

Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with Cinchona Alkaloids: Induction of Fetal Hemoglobin Production
por: Zuccato, Cristina, et al.
Publicado: (2021)

A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta‐Thalassemia and Sickle Cell Disease
por: Cai, Liuhong, et al.
Publicado: (2017)

PB2235: COMPLETE DELETION OF THE CACCC BOX OF THE HBB GENE PROMOTER: A NEW MECHANISM LEADING TO A SILENT PHENOTYPE OF BETA THALASSEMIA
por: Mondesert, E., et al.
Publicado: (2022)

Prenatal diagnosis of a rare β‐thalassemia gene －90 (C>T) (HBB: c.‐140 C>T) mutation associated with deletional Hb H disease (‐‐(SEA)/‐α (4.2))
por: Qian, Hou, et al.
Publicado: (2020)

The Clinical Significance of the Spectrum of Interactions of the Rare IVS-II-5 G>C (HBB: c.315+5 G>C) Variation with Other β-Thalassemia Mutations in Southern China
por: Liao, Guiping, et al.
Publicado: (2022)

Compound heterozygote of Hb D(Iran) [HBB: c.67G>C, β 22(B4) Glu>Gln] with β(0)-thalassemia [cds 41/42 (-CTTT)] from Eastern India
por: Mohanty, Pradeep Kumar, et al.
Publicado: (2018)

Generation of an immortalised erythroid cell line from haematopoietic stem cells of a haemoglobin E/β-thalassemia patient
por: Trakarnsanga, Kongtana, et al.
Publicado: (2020)

Interaction of Borrelia burgdorferi Hbb with the p66 promoter
por: Medrano, Melisa S., et al.
Publicado: (2010)

Multi-omic profiling of pituitary thyrotropic cells and progenitors
por: Daly, Alexandre Z., et al.
Publicado: (2021)

HBB Gene Mutations and Their Pathological Impacts on HbE/β-Thalassaemia in Kuala Terengganu, Malaysia
por: Saad, Hanan Kamel M., et al.
Publicado: (2023)

In Vitro Study of Ineffective Erythropoiesis in Thalassemia: Diverse Intrinsic Pathophysiological Features of Erythroid Cells Derived from Various Thalassemia Syndromes
por: Kaewsakulthong, Woratree, et al.
Publicado: (2022)

Isolation and characterization of the erythroid progenitor cell: CFU-E
Publicado: (1983)

Single-cell profiling of human megakaryocyte-erythroid progenitors identifies distinct megakaryocyte and erythroid differentiation pathways
por: Psaila, Bethan, et al.
Publicado: (2016)

Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis
por: Liang, Raymond, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_823lclprjvv50do1t4fvvfleor